Knockdown of RAMP1 in prostate cancer cells blocks the expression of MAP2KI (Dual specificity mitogen-activated protein kinase 1) and p-ERK1/2 (phosphorylated-extracellular signal-regulated kinase 1/2). This evidence concerns the gene MAPK3 and prostate carcinoma.